Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Tiedemann Advisors LLC

Share on StockTwits

Tiedemann Advisors LLC lessened its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 68.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,002 shares of the medical research company’s stock after selling 4,439 shares during the period. Tiedemann Advisors LLC’s holdings in Thermo Fisher Scientific were worth $588,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BlackRock Inc. boosted its holdings in Thermo Fisher Scientific by 1.4% in the 2nd quarter. BlackRock Inc. now owns 27,643,905 shares of the medical research company’s stock valued at $8,118,461,000 after purchasing an additional 392,227 shares in the last quarter. RMB Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific by 8.4% during the 2nd quarter. RMB Capital Management LLC now owns 11,264 shares of the medical research company’s stock worth $3,308,000 after acquiring an additional 872 shares in the last quarter. InterOcean Capital LLC boosted its stake in shares of Thermo Fisher Scientific by 1.7% during the 2nd quarter. InterOcean Capital LLC now owns 4,501 shares of the medical research company’s stock worth $1,322,000 after acquiring an additional 75 shares in the last quarter. Dana Investment Advisors Inc. boosted its stake in shares of Thermo Fisher Scientific by 444.0% during the 2nd quarter. Dana Investment Advisors Inc. now owns 95,932 shares of the medical research company’s stock worth $28,173,000 after acquiring an additional 78,296 shares in the last quarter. Finally, HighTower Advisors LLC boosted its stake in shares of Thermo Fisher Scientific by 8.0% during the 2nd quarter. HighTower Advisors LLC now owns 61,538 shares of the medical research company’s stock worth $18,056,000 after acquiring an additional 4,554 shares in the last quarter. Hedge funds and other institutional investors own 88.19% of the company’s stock.

Shares of Thermo Fisher Scientific stock traded up $2.68 during trading on Friday, hitting $297.65. 1,050,015 shares of the company were exchanged, compared to its average volume of 1,349,471. The company has a quick ratio of 1.07, a current ratio of 1.49 and a debt-to-equity ratio of 0.58. Thermo Fisher Scientific Inc. has a fifty-two week low of $208.34 and a fifty-two week high of $305.45. The stock has a market capitalization of $118.13 billion, a price-to-earnings ratio of 26.77, a P/E/G ratio of 1.93 and a beta of 1.12. The firm has a 50 day moving average price of $281.12 and a 200 day moving average price of $276.59.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a return on equity of 17.11% and a net margin of 14.24%. The firm had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same period in the previous year, the firm posted $2.75 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Analysts predict that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be given a dividend of $0.19 per share. The ex-dividend date is Monday, September 16th. This represents a $0.76 annualized dividend and a dividend yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

TMO has been the topic of several research analyst reports. Wolfe Research initiated coverage on Thermo Fisher Scientific in a research note on Thursday, May 30th. They set an “outperform” rating on the stock. BTIG Research boosted their price target on Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price target on the stock in a research note on Wednesday, June 12th. UBS Group lifted their price objective on Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a research report on Thursday, May 23rd. Finally, Barclays set a $330.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Monday, July 15th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $303.17.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total value of $14,241,500.00. Following the completion of the transaction, the chief executive officer now directly owns 342,193 shares in the company, valued at approximately $97,466,832.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jim P. Manzi sold 1,833 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $272.93, for a total value of $500,280.69. Following the completion of the transaction, the director now owns 28,592 shares of the company’s stock, valued at $7,803,614.56. The disclosure for this sale can be found here. Insiders own 0.45% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: How do CD ladders protect against rising interest rates?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.